NHS National Generic Pharmaceuticals Wave 13

Concepts

• pharmaceutical products
• nhs national generic pharmaceuticals
• runcorn
• nhs national generic pharmaceuticals wave
• period of framework agreement
• total maximum duration of the framework agreement
• authority's sole discretion
• potential periods of call
• oral products
• march

Location

Description

Tender Close: 26th July 2021, 13:00. Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 09 - Stability Data Requirements https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nN/HWcptyRHiN0... Document No. 00 - Read Me First Document https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nB/5TJmbuA3I3Y... Document No. 02 - Terms of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1mx/7DZLy_mc15T... Document No. 07a - Quality control technical sheet https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1na/_.Uxru4eGKJ... Document No. 05a (v) Product Listing and Usage Hospital Only https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nV/V3nlLWBpSNY... Document No. 01 - Invitation to offer covering letter https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nC/U6RJLEyypAE... Document No. 06 - Form of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nS/S0CGPE34WHh... Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nf/s13sx0g5pfe... Document No. 03 - Framework Agreement and Terms and Conditions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nQ/dynJ8xFeJ6b... Document No. 04 - Contract technical specification https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nL/YJ7dfbIDenE... Document No. 05a (i) Product Listing and Usage Everolimus https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nM/U9jGL1j68pb... Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_17_5532 SELECTT Application https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nW/x8YQQEhycg2... Document No. 05a (iii) Product Listing and Usage Orals https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1ng/BZ78U7s18yI... Document No. 05b - Selectt offer schedule instructions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nR/uH_rF2f7XLR... Document No. 08 - Confidential information schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1nD/FFusdEVpdca... FTS Notice - NHS National Generic Pharmaceuticals Wave 13 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000Q1ox/oJRk9p3S5CC...